Strong and diffuse immunopositivity or identification of TP53 mutation differentiates IDH mutant astrocytoma from IDH mutant oligodendroglioma (Takami et al., 2015). This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).